70 likes | 164 Views
Annual General Meeting Working group sessions. A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE. Testing foundations, building achievements. Taking stock of EPF – Accomplishments over the last 4 years, A few of the challenges ahead
E N D
Annual General Meeting Working group sessions A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE
Testing foundations, building achievements • Taking stock of EPF – Accomplishments over the last 4 years, • A few of the challenges ahead • Future opportunities for us to generate real societal change and make a difference for patients across the EU • THREE QUESTIONS FOR DISCUSSION
Accomplishments over last 4 years Real evidence of policy impact in the Commission and the European Parliament • Membership doubled and increasing • Effective outreach and capacity building, through regional seminars and Manfesto Campaign • High quality projects that support our policy work • Value + Project • Strong governance policies and procedures that reflect our core values and principles
Accomplishments over last 4 years • Committed board, secretariat and policy advisory group • Good financial management, diversification and transparency • High visibility – communications and presence at many EU health meetings • Increasing level of trust and collaboration among other health stakeholders • THIS IS A JOURNEY ............
Some challenges ahead • Managing growth, without overstretching the membership, board or secretariat • Fostering trust and unity across our diverse membership • Building membership in underrepresented countries/ disease areas • Translating our policy advances at EU level to patient centred policy at national level • Prioritising -focus on where we really make a difference • Building long term financial stability, whilst combatting scepticism because of industry funding
Future opportunities - examples • Embedding ‘ patient involvement’ in all EU health related programmes ( 2014 -2020) building on Value + • Building stronger relationships with spectrum of decision makers, including national governments • Achieving substantial impact in core EU health policy growth areas , e.g eHealth, Research and Innovation, sustainability and quality of health systems • Promoting new models of financing patient groups • Core funding from the European Commission , new industry sectors, Public Private Partnerships
Three questions • How can we build and grow EPF based on our key achievements and challenges to date? • How can our membership best guide, strengthen and reinforce EPF to the benefit of all our members? • Where would we really like to be in 2020 as a European Patients’ Movement?